rivaroxaban has been researched along with Pulmonary-Veno-Occlusive-Disease* in 2 studies
2 other study(ies) available for rivaroxaban and Pulmonary-Veno-Occlusive-Disease
Article | Year |
---|---|
A 77-Year-Old Woman With Acute Shortness of Breath and Chest Pain.
A 77-year-old woman presented to the hospital with symptoms of progressive shortness of breath with associated right-sided pleuritic pain. The patient had begun noting dyspnea on exertion, limiting her ability to go on hikes over the few days prior to admission. Her medical history is significant for carcinoid tumor status postresection in 2012 without recurrence. She has no history of thromboembolism or clotting disorders, and she has no history of smoking or drug abuse. Current medications include amlodipine, celecoxib, hydrochlorothiazide, and rosuvastatin. Topics: Acute Disease; Aged; Chest Pain; Dyspnea; Echocardiography; Factor Xa Inhibitors; Female; Humans; Pulmonary Veno-Occlusive Disease; Rivaroxaban; Tomography, X-Ray Computed; Venous Thrombosis | 2018 |
Rivaroxaban lessens the number of thrombi in the left atrium and right lower pulmonary vein, as illustrated by transoesophageal echocardiography but not 80-MDCT.
Stroke is a clinically important problem. A left atrial thrombus is known as a cause of ischaemic stroke. A pulmonary vein thrombus (PVT) is thought to be rare; however, PVT is common in elderly patients. Additionally, images of PVT with transoesophageal echocardiography (TEE) following treatment have not been well contrasted with that from either 64 or 80-slice multidetector CT (80-MDCT). The images of such changes depicted by TEE remain unknown. An 87-year-old man with hypertension was examined by 80-MDCT and TEE to check the cardiac thrombus. Although 80-MDCT did not depict the thrombus, TEE depicted the thrombus in the left atrium and right lower pulmonary vein (RLPV) clearly. After 6 months of rivaroxaban treatment, the thrombus in the RLPV decreased slightly and the thrombus in the left atrium became small and lucent, as estimated with TEE. Rivaroxaban decreased the size of the thrombus and changed the quality of the thrombus. Topics: Aged, 80 and over; Drug Administration Schedule; Echocardiography, Transesophageal; Factor Xa Inhibitors; Heart Atria; Heart Diseases; Humans; Male; Multidetector Computed Tomography; Pulmonary Veins; Pulmonary Veno-Occlusive Disease; Rivaroxaban; Thrombosis; Venous Thrombosis | 2017 |